The pharmaceutical excipients market is poised for substantial growth, with the global market size estimated to reach US$9.63 billion by 2025, and projected to expand to US$17.38 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2025 to 2032. Excipients are vital components of pharmaceutical formulations, acting as the medium that enables the effective delivery of active pharmaceutical ingredients (APIs). The increasing demand for patient-centric drug delivery systems, rising production of generic medicines, and advancements in biologics are some of the key drivers propelling the market forward.
Key Industry Highlights
Dominant Functionality: Fillers & Diluents
The fillers and diluents segment is expected to hold the largest market share, estimated at 41.2% in 2025. This dominance is attributed to their crucial role in the formulation of oral solid dosage forms, including tablets and capsules, which constitute the majority of pharmaceutical products globally. These excipients provide necessary bulk and consistency to the drug products, facilitating easier administration and absorption.
Fastest-Growing Functionality Segment: Coating Materials
The coating materials segment is anticipated to exhibit the highest growth rate throughout the forecast period. The demand for these excipients is driven by the increasing need for advanced drug delivery systems, including controlled-release and taste-masking formulations. Coatings also protect sensitive ingredients and enhance the stability of pharmaceutical products, particularly for pediatric, geriatric, and chronic disease patients.
Leading Dosage Form: Solid Dosage Forms
Solid dosage forms, including tablets and capsules, are set to dominate the pharmaceutical excipients market, holding an estimated market share of 68.0% in 2025. The widespread consumption of solid dosage forms, especially in chronic disease management, fuels the demand for excipients such as binders, fillers, and disintegrants. These formulations are cost-effective, stable, and offer convenience, making them the preferred choice for pharmaceutical companies worldwide.
Download Your Free Sample & Explore Key Insights: https://www.persistencemarketresearch.com/samples/4421
Leading Region: North America
North America will continue to lead the market, commanding an estimated share of 40.7% in 2025. This region’s dominance is supported by its robust pharmaceutical industry, regulatory framework, and the prevalence of cutting-edge biopharmaceutical innovation. The U.S. pharmaceutical sector, in particular, is investing heavily in advanced manufacturing techniques and research and development (R&D) to meet the growing demand for specialized excipients.
Fastest-Growing Regional Market: Asia Pacific
Asia Pacific is projected to be the fastest-growing region for pharmaceutical excipients, with the highest CAGR forecast through 2032. Key drivers include the rapidly expanding pharmaceutical manufacturing capabilities in countries such as India and China, coupled with rising healthcare investments. India, in particular, benefits from its status as the world’s leading exporter of generic drugs, fueling the demand for excipients in large volumes.
Market Factors – Growth, Barriers, and Opportunities
Patent Expirations and Surge in Generic Drug Production
The expiration of patents for blockbuster drugs has created a significant opportunity for generic drug manufacturers. Between 2025 and 2029, it is estimated that US$63.7 billion worth of small-molecule drugs will go off-patent, and this trend is expected to continue into the following decade. As a result, the demand for pharmaceutical excipients will increase, especially in emerging markets where cost-effective excipients play a crucial role in the formulation of generics.
Generics manufacturers are heavily reliant on excipients such as fillers, binders, and stabilizers to produce low-cost, high-quality drugs quickly. This demand surge is further supported by the Loss of Exclusivity (LoE) opportunities, valued at US$180 billion in the U.S. and EU through 2035.
Impact of U.S. Tariffs on Pharmaceutical Imports
The U.S. introduced tariff hikes on pharmaceutical imports, particularly on Chinese active pharmaceutical ingredients (APIs), which have the potential to disrupt the global excipients supply chain. With tariffs on certain APIs reaching up to 245%, pharmaceutical companies in the U.S. may face increased production costs, particularly for generic drugs. This may result in higher prices for consumers and could impede the access to affordable medicines, especially for low-income patients.
Rising Demand for Patient-Centric Formulations
The shift toward patient-centric drug delivery systems has fueled demand for excipients that improve drug solubility, taste-masking, and controlled-release properties. The increasing focus on personalized medicine, which caters to specific patient groups, including pediatric and geriatric populations, is driving innovation in excipient technologies. For example, advanced oral suspension formulations that cater to adults and geriatric patients who have difficulty swallowing tablets have gained popularity, creating opportunities for excipient manufacturers to innovate in dosage forms.
Get Custom Insights Designed for Your Business: https://www.persistencemarketresearch.com/request-customization/4421
Category-wise Analysis
Functionality Insights
The fillers and diluents segment, as mentioned earlier, holds a dominant share of the market. These excipients are essential in solid oral dosage forms like tablets and capsules, which are widely consumed for chronic disease therapies. In the coming years, the demand for these excipients will continue to rise, driven by the ongoing expansion of generics manufacturing in key markets such as India and China.
On the other hand, the coating materials segment is expected to experience the highest growth rate through 2032. Coatings are essential for protecting sensitive ingredients, enhancing drug stability, and controlling the release of active ingredients. This is particularly important in the development of advanced drug delivery systems and in improving patient compliance with medications.
Dosage Form Insights
Solid dosage forms are forecasted to dominate the pharmaceutical excipients market with 68.0% market share in 2025. These forms are easy to manufacture, stable, and offer a broad range of therapeutic applications. The demand for controlled-release and taste-masked tablets is expected to increase, particularly for chronic disease treatments.
However, the liquid dosage form segment is expected to exhibit the highest CAGR due to the growing demand for pediatric and geriatric-friendly formulations. These formulations are often easier to swallow and more suitable for patients with specific needs. Additionally, innovations in excipients that improve solubility, stability, and flavor masking are likely to expand the market for liquid pharmaceutical products.
Regional Insights
North America
North America will continue to hold a significant share of the pharmaceutical excipients market, driven by its well-established pharmaceutical industry, rigorous regulatory environment, and increasing demand for biologics and specialty drugs. The U.S., in particular, is a key player in the development of multifunctional excipients that cater to the growing demand for biologics-compatible and high-purity formulations.
Asia Pacific
Asia Pacific is the fastest-growing regional market for pharmaceutical excipients, driven by the expanding pharmaceutical manufacturing sectors in India and China. India, known as the “pharmacy of the world,” is home to over 300 generic drug approvals annually in the U.S., presenting a lucrative opportunity for excipient manufacturers. The region’s growth is further supported by favorable government policies aimed at boosting local pharmaceutical production.
Europe
Europe holds a mature and highly regulated pharmaceutical market, with a significant share of around 24.1% in 2025. The region is witnessing a growing demand for sustainable excipients and plant-based alternatives, aligned with environmental and circular economy principles. The increasing adoption of biologics, biosimilars, and advanced drug delivery systems is expected to drive the demand for specialized excipients in Europe.
Competitive Landscape
The global pharmaceutical excipients market is highly competitive, with several key players investing heavily in product innovation and strategic partnerships. Leading companies such as BASF, DuPont, and Roquette Frères are at the forefront of developing multifunctional excipients designed for complex drug delivery systems. The race for innovation is intensifying with the rise of biopolymers, nanoexcipients, and sustainable excipients.
Checkout Now & Download Complete Market Report: https://www.persistencemarketresearch.com/checkout/4421
Market Segmentation
By Functionality
- Binders & Adhesives
- Fillers & Diluents
- Disintegrants
- Lubricants & Glidants
- Coating Materials
- Others
By End-user
- Pharmaceutical & Biopharmaceutical Companies
- Contract Formulators
- Research Organizations
- Academic Institutions
By Dosage Form
- Solid
- Semi-Solid
- Liquid
By Route of Administration
- Oral
- Parenteral
- Topical
- Others
By Region
- North America
- Europe
- East Asia
- South Asia & Oceania
- Latin America
- Middle East & Africa
Key Industry Developments
Several notable industry developments highlight the growing investments in pharmaceutical excipients. For instance, in July 2025, Sigachi Industries opened a new R&D center in Hyderabad to focus on API development and strengthen its position in regulated markets. Similarly, in June 2025, BASF inaugurated a new GMP Solution Center in Michigan, focusing on biopharmaceutical and pharmaceutical ingredients.
Conclusion
The pharmaceutical excipients market is poised for significant growth driven by the increasing demand for generics, patient-centric drug delivery systems, and biologics. While regional dynamics differ, with North America maintaining dominance and Asia Pacific emerging as the fastest-growing region, the market as a whole presents significant opportunities for innovation. As pharmaceutical companies continue to innovate and develop complex, patient-specific formulations, excipients will play an increasingly critical role in shaping the future of drug development and delivery.
